- Home
- OPT vs FF Comparison
OPT vs FF Comparison
Compare OPT & FF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- FF
- Stock Information
- Founded
- OPT 1984
- FF N/A
- Country
- OPT Australia
- FF United States
- Employees
- OPT N/A
- FF N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- FF Major Chemicals
- Sector
- OPT Health Care
- FF Industrials
- Exchange
- OPT Nasdaq
- FF Nasdaq
- Market Cap
- OPT 615.5M
- FF 270.9M
- IPO Year
- OPT 2020
- FF N/A
- Fundamental
- Price
- OPT $5.03
- FF $6.11
- Analyst Decision
- OPT Strong Buy
- FF Strong Buy
- Analyst Count
- OPT 1
- FF 1
- Target Price
- OPT $12.00
- FF $0.80
- AVG Volume (30 Days)
- OPT 41.7K
- FF 264.1K
- Earning Date
- OPT 08-30-2024
- FF 11-08-2024
- Dividend Yield
- OPT N/A
- FF 3.93%
- EPS Growth
- OPT N/A
- FF N/A
- EPS
- OPT N/A
- FF 0.91
- Revenue
- OPT $261,859.00
- FF $339,451,000.00
- Revenue This Year
- OPT N/A
- FF N/A
- Revenue Next Year
- OPT $62,429.18
- FF N/A
- P/E Ratio
- OPT N/A
- FF $6.74
- Revenue Growth
- OPT N/A
- FF N/A
- 52 Week Low
- OPT $1.60
- FF $4.15
- 52 Week High
- OPT $5.45
- FF $8.36
- Technical
- Relative Strength Index (RSI)
- OPT 72.24
- FF 57.01
- Support Level
- OPT $4.70
- FF $6.04
- Resistance Level
- OPT $5.45
- FF $6.36
- Average True Range (ATR)
- OPT 0.32
- FF 0.18
- MACD
- OPT 0.01
- FF 0.02
- Stochastic Oscillator
- OPT 73.35
- FF 67.28
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.